Atlas Trials

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Clinical trial NCT01015833 · COMPLETED

Trial details

NCT number
NCT01015833
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7Stage IIIA Hepatocellular Carcinoma AJCC v7Stage IIIB Hepatocellular Carcinoma AJCC v7Stage IIIC Hepatocellular Carcinoma AJCC v7Stage IV Hepatocellular Carcinoma AJCC v7Stage IVA Hepatocellular Carcinoma AJCC v7Stage IVB Hepatocellular Carcinoma AJCC v7Unresectable Hepatocellular Carcinoma
Start date
2010-02-15
Primary completion
2015-05-21
Enrollment
356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.